Taiwan's Locus Cell poised to capture global biopharma shift at BIOJAPAN 2024

Taiwan's Locus Cell poised to capture global biopharma shift at BIOJAPAN 2024

The ongoing US-China tech war has significantly impacted the global biotech landscape, particularly with the recent passage of the US Biosecurity Act.
Investment builds on biotech potential

Investment builds on biotech potential

Vietnam’s biotech sector is gaining momentum as both foreign and local players step up investments, which are expected to realise the country’s ambition to become a top 10 regional biotech hub.
Fujifilm ups US biotech plant investment by $1.2 bn

Fujifilm ups US biotech plant investment by $1.2 bn

Fujifilm said Friday it would increase its investment in a planned biotech plant in North Carolina by $1.2 billion at a time when Japan-US trade ties are in the spotlight.
AstraZeneca buys French biotech firm Amolyt for $1 bn

AstraZeneca buys French biotech firm Amolyt for $1 bn

Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs.
GM crops continue to grow

GM crops continue to grow

The world is witnessing strong development of commercialised biotech crops.